首站-论文投稿智能助手
典型文献
Surgical exploration with non-resection in the setting of resectable,borderline and locally advanced pancreatic cancer
文献摘要:
Pancreatic cancer has an overall dismal prognosis compared to most other malignancies.In general,only about 15%-20%of pa-tients are deemed upfront resectable at time of diagnosis,with a similar proportion presenting with either borderline or locally advanced disease[1].Novel and more effective treatment reg-imens including FOLFIRINOX have made yet more patients be-come resectable,with up to 60%reported in some centers[2].Technical advances in surgery continue to literally explore new anatomical territory[3].More aggressive attitude towards resec-tion of involved vessels has provided opportunity for curative at-tempt resections,even for a subpopulation of biological respon-ders staged with pre-treatment unresectable disease[4,5].How-ever,while surgery is the dominant modality for a potential cu-rative approach to pancreatic cancer,there is a subgroup of pa-tients scheduled for surgery who ends up with an aborted resec-tion during explorative laparotomy,also referred to as an"open-close laparotomy".The reasons for such non-resection events are manyfold and have likely changed over time.Indeed,in one Ital-ian study the non-resection rate remained constant at about 25%over two decades[6].While many institutional series report non-resection rates in the same range,these figures may be influenced by patient selection,referral patterns and institutional policies to-wards resection and surgical aggressiveness[2,4,6].
文献关键词:
作者姓名:
Kjetil S?reide
作者机构:
Department of Gastrointestinal Surgery,HPB Unit,Stavanger University Hospital,P.O.Box 8100,Stavanger N-4068,Norway;Department of Clinical Medicine,University of Bergen,Bergen,Norway
引用格式:
[1]Kjetil S?reide-.Surgical exploration with non-resection in the setting of resectable,borderline and locally advanced pancreatic cancer)[J].国际肝胆胰疾病杂志(英文版),2022(03):205-206
A类:
upfront,tempt,manyfold,Ital
B类:
Surgical,exploration,setting,borderline,locally,advanced,pancreatic,cancer,Pancreatic,has,overall,dismal,prognosis,compared,most,other,malignancies,general,only,about,deemed,diagnosis,similar,proportion,presenting,either,disease,Novel,more,effective,treatment,reg,imens,including,FOLFIRINOX,have,made,yet,patients,be,come,reported,some,centers,Technical,advances,surgery,continue,literally,explore,new,anatomical,territory,More,attitude,towards,involved,vessels,provided,opportunity,curative,resections,subpopulation,biological,respon,ders,staged,unresectable,How,ever,while,dominant,modality,potential,approach,there,subgroup,scheduled,who,ends,aborted,during,explorative,laparotomy,also,referred,open,close,reasons,such,events,likely,changed,Indeed,one,ian,study,remained,constant,two,decades,While,institutional,series,rates,same,range,these,figures,may,influenced,by,selection,referral,patterns,policies,surgical,aggressiveness
AB值:
0.587907
相似文献
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
An international multicentric phase Ⅲ randomized controlled trial of time-acupoints-space acupuncture for the prevention of chemotherapy-induced fatigue in patients with early stage breast cancer:a study protocol
Saghachian Mahasti;Barry Caroline;Asselain Bernard;LI Yunfen;NIE Jianyun;LIU Dequan;CHEN Dedian;CHEN Chunxin;Laura Estevez;LI Wenhui;Jean-Pierre Armand;ZHU Miansheng;JU Liya-Institute Gustave Roussy,Paris,France;Research Center of Epidemiology and public health,Paris,France;Institute Curie of Paris,Paris,France;Yunnan Cancer Hospital,Third Affiliated Hospital of Kunming Medical University,Kunming,China;PreciMed Platform Europe,Paris,France,,MD Anderson Cancer Hospital,Madrid,Spain;ARIATAS Association pour la Recherche et l'Information de l'Acupuncture Time-Acupoints-Space,Paris,France
Does reconstruction affect outcomes following exclusively endoscopic endonasal resection of benign orbital tumors: A systematic review with meta-analysis
Lehmann Ashton E.;von Sneidern Manuela;Shen Sarek A.;Humphreys Ian M.;Abuzeid Waleed M.;Jafari Aria-Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA;Department of Otolaryngology-Head and Neck Surgery, Geisinger Medical Center, Danville, Pennsylvania, USA;Department of Otolaryngology-Head and Neck Surgery, New York University School of Medicine, New York, New York, USA;Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA;Division of Rhinology and Endoscopic Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。